These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

845 related items for PubMed ID: 21163672

  • 1. Elevation of human tumor necrosis factor-like weak inducer of apoptosis in peripheral blood mononuclear cells is correlated with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
    Liu ZC, Zhou QL, Li XZ, Yang JH, Ao X, Veeraragoo P, Zuo XX.
    Cytokine; 2011 Mar; 53(3):295-300. PubMed ID: 21163672
    [Abstract] [Full Text] [Related]

  • 2. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) mediates p38 mitogen-activated protein kinase activation and signal transduction in peripheral blood mononuclear cells from patients with lupus nephritis.
    Zhi-Chun L, Qiao-Ling Z, Zhi-Qin L, Xiao-Zhao L, Xiao-xia Z, Rong T.
    Inflammation; 2012 Jun; 35(3):935-43. PubMed ID: 22009442
    [Abstract] [Full Text] [Related]

  • 3. [Expression of monocyte chemoattractant protein-1 and lupus nephritis].
    Liu ZJ, Lin JY.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Aug; 27(4):491-5. PubMed ID: 16178446
    [Abstract] [Full Text] [Related]

  • 4. [Expression of tumor necrosis factor-alpha signaling adapter proteins in peripheral blood mononuclear cells from patients with systemic lupus erythematosus].
    Zhu LJ, Yang X, Chen WY, Li XY, Ji YL, Mao HP, Nie J, Yu XQ.
    Zhonghua Yi Xue Za Zhi; 2007 Nov 27; 87(44):3102-6. PubMed ID: 18269865
    [Abstract] [Full Text] [Related]

  • 5. Expression of high mobility group box chromosomal protein 1 and its modulating effects on downstream cytokines in systemic lupus erythematosus.
    Li J, Xie H, Wen T, Liu H, Zhu W, Chen X.
    J Rheumatol; 2010 Apr 27; 37(4):766-75. PubMed ID: 20110525
    [Abstract] [Full Text] [Related]

  • 6. Relationship of oncogenes (sFas, Bcl-2) and cytokines (IL-10, alfa-TNF) with the activity of systemic lupus erythematosus.
    Miret C, Font J, Molina R, Garcia-Carrasco M, Filella X, Ramos M, Cervera R, Ballesta A, Ingelmo M.
    Anticancer Res; 2001 Apr 27; 21(4B):3053-9. PubMed ID: 11712810
    [Abstract] [Full Text] [Related]

  • 7. Expression of chemokine and fibrosing factor messenger RNA in the urinary sediment of patients with lupus nephritis.
    Chan RW, Lai FM, Li EK, Tam LS, Wong TY, Szeto CY, Li PK, Szeto CC.
    Arthritis Rheum; 2004 Sep 27; 50(9):2882-90. PubMed ID: 15457456
    [Abstract] [Full Text] [Related]

  • 8. Up-regulation of TRAIL mRNA expression in peripheral blood mononuclear cells from patients with active systemic lupus erythematosus.
    Komatsuda A, Wakui H, Iwamoto K, Togashi M, Maki N, Masai R, Hatakeyama T, Sawada K.
    Clin Immunol; 2007 Oct 27; 125(1):26-9. PubMed ID: 17683987
    [Abstract] [Full Text] [Related]

  • 9. Elevated expression of the Brn-3a and Brn-3b transcription factors in systemic lupus erythematosus correlates with antibodies to Brn-3 and overexpression of Hsp90.
    Ripley BJ, Rahman MA, Isenberg DA, Latchman DS.
    Arthritis Rheum; 2005 Apr 27; 52(4):1171-9. PubMed ID: 15818685
    [Abstract] [Full Text] [Related]

  • 10. Expression of human tumor necrosis factor-like weak inducer of apoptosis in patients with systemic lupus erythematosus.
    Wang C, Chen LL, Pan HF, Leng RX, Qin WZ, Ye DQ.
    Clin Rheumatol; 2012 Feb 27; 31(2):335-9. PubMed ID: 21968693
    [Abstract] [Full Text] [Related]

  • 11. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
    Mahmoud RA, El-Gendi HI, Ahmed HH.
    Clin Biochem; 2005 Feb 27; 38(2):134-41. PubMed ID: 15642275
    [Abstract] [Full Text] [Related]

  • 12. Increased expression of soluble inducible costimulator ligand (ICOSL) in patients with systemic lupus erythematosus.
    Her M, Kim D, Oh M, Jeong H, Choi I.
    Lupus; 2009 May 27; 18(6):501-7. PubMed ID: 19395451
    [Abstract] [Full Text] [Related]

  • 13. Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
    Feng X, Wu H, Grossman JM, Hanvivadhanakul P, FitzGerald JD, Park GS, Dong X, Chen W, Kim MH, Weng HH, Furst DE, Gorn A, McMahon M, Taylor M, Brahn E, Hahn BH, Tsao BP.
    Arthritis Rheum; 2006 Sep 27; 54(9):2951-62. PubMed ID: 16947629
    [Abstract] [Full Text] [Related]

  • 14. TRAIL mRNA expression in peripheral blood mononuclear cells of Egyptian SLE patients.
    El-Karaksy SM, Kholoussi NM, Shahin RM, El-Ghar MM, Gheith Rel-S.
    Gene; 2013 Sep 15; 527(1):211-4. PubMed ID: 23792015
    [Abstract] [Full Text] [Related]

  • 15. Expression of matrix metalloproteinase-1 mRNA in peripheral blood mononuclear cells of systemic lupus erythematosus patients and its relationship with atherosclerosis.
    Zhang HY, Bao SM, Shou WL, Luan HX, Zhang Y, Feng X, Tong DW, Zhang SL, Hu CJ, Zeng XF, Li YZ.
    Chin Med J (Engl); 2009 Nov 05; 122(21):2593-7. PubMed ID: 19951575
    [Abstract] [Full Text] [Related]

  • 16. Down-regulation of TIPE2 mRNA expression in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
    Li D, Song L, Fan Y, Li X, Li Y, Chen J, Zhu F, Guo C, Shi Y, Zhang L.
    Clin Immunol; 2009 Dec 05; 133(3):422-7. PubMed ID: 19748832
    [Abstract] [Full Text] [Related]

  • 17. Toll-like receptor 9 is correlated to disease activity in Chinese systemic lupus erythematosus population.
    Mu R, Sun XY, Lim LT, Xu CH, Dai CX, Su Y, Jia RL, Li ZG.
    Chin Med J (Engl); 2012 Aug 05; 125(16):2873-7. PubMed ID: 22932083
    [Abstract] [Full Text] [Related]

  • 18. Serum soluble interleukin 7 receptor is strongly associated with lupus nephritis in patients with systemic lupus erythematosus.
    Badot V, Luijten RK, van Roon JA, Depresseux G, Aydin S, Van den Eynde BJ, Houssiau FA, Lauwerys BR.
    Ann Rheum Dis; 2013 Mar 05; 72(3):453-6. PubMed ID: 23264357
    [Abstract] [Full Text] [Related]

  • 19. Relationship of serum TWEAK level to cytokine level, disease activity, and response to anti-TNF treatment in patients with rheumatoid arthritis.
    Park MC, Chung SJ, Park YB, Lee SK.
    Scand J Rheumatol; 2008 Mar 05; 37(3):173-8. PubMed ID: 18465450
    [Abstract] [Full Text] [Related]

  • 20. Serum TWEAK as a biomarker for disease activity of systemic lupus erythematosus.
    Choe JY, Kim SK.
    Inflamm Res; 2016 Jun 05; 65(6):479-88. PubMed ID: 26921306
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.